Ocugen Inc is a biotechnology company focused on developing innovative therapies to treat diseases of the eye. With an emphasis on addressing unmet medical needs, the company is particularly known for its work in gene therapy and regenerative medicine. Ocugen is actively engaged in research and development of treatments for conditions such as retinal diseases, including a noteworthy collaboration to advance novel gene therapies that could potentially restore vision. Through its commitment to scientific advancement and patient care, Ocugen aims to bring transformative solutions to the field of ophthalmology.